by Menchise, V. et al.
Institute for Biostructures and Bioimages (CNR) c/o Molecular Biotechnology Center (University of Turin), Via Nizza 52, I-10126 Torino, Italy
Institute for Biostructures and Bioimages (CNR) c/o Molecular Biotechnology Center (University of Turin), Via Nizza 52, I-10126 Torino, Italy
In vivo labeling of b16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Mol. Pharm. 2011; 5:1750-6